Chad Conner is an experienced executive and healthcare professional with a diverse background in the hemp, pharmaceutical, and wellness industries. Currently serving as the President of Nova Aurora, Chad leads initiatives in creating innovative ingredients from waste materials in the hemp and psilocybin sectors. Chad also holds the position of Executive Vice President of Operations and Finance at TradeHelp™, a platform facilitating real-time trading of commodities and services. Prior roles include Chief Executive Officer of Mycrodose Therapeutics, where advanced drug delivery systems were developed to address mental health issues, and President of Kelai Pharmaceutical, which aimed to combine natural molecules with advanced drug delivery technologies. Further experience includes founding Pure Ratios, leading International Bioceutical Company LLC, and co-founding Pavana Pharmaceuticals, all focused on therapeutic applications of cannabinoids. Academic qualifications include a Master of Science in Traditional Chinese Medicine and Chinese Herbology from the Pacific College of Health and Science.